Alzamend Neuro has partnered with Massachusetts General Hospital to conduct a pioneering Phase II clinical trial of its AL001 treatment for PTSD, led by Dr. Ovidiu Andronesi.
Tag: Alzamend Neuro
Bitcoin(BTC)$63,330.655.98%
Ethereum(ETH)$2,470.187.42%
Tether USDt(USDT)$1.000.01%
BNB(BNB)$568.195.22%
Solana(SOL)$143.5912.23%
USDC(USDC)$1.000.00%
XRP(XRP)$0.594.02%
Dogecoin(DOGE)$0.1063896.16%
Toncoin(TON)$5.775.00%
TRON(TRX)$0.1514751.24%